Every SEC Form 3/4/5 on record for this filer (CIK 1722140) — 5 issuers, 40 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | 2025-05-29 → 2026-05-11 | 3 | — |
| RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer · Director | 2024-06-06 → 2026-02-19 | 10 | −$3M |
| PCRX | Pacira BioSciences, Inc. | Director | 2023-10-11 → 2025-09-08 | 5 | −$64,005 |
| CERE | Cerevel Therapeutics Holdings, Inc. | President · lapsed | 2021-05-13 → 2023-02-08 | 8 | −$3M |
| SCPH | scPharmaceuticals Inc. | Chief Operating Officer · lapsed | 2017-11-16 → 2018-01-19 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RAPP | 2026-02-18 | Sell | 2,281 | $29.80 | $67,974 | 556,247 |
| RAPP | 2026-02-18 | Sell | 2,983 | $29.04 | $86,626 | 22,829 |
| RAPP | 2026-02-18 | Sell | 2,100 | $29.80 | $62,580 | 20,729 |
| RAPP | 2026-02-18 | Sell | 3,552 | $29.05 | $103,186 | 558,528 |
| RAPP | 2026-01-20 | Sell | 5,833 | $26.12 | $152,358 | 562,080 |
| RAPP | 2026-01-20 | Sell | 5,083 | $26.11 | $132,717 | 25,812 |
| RAPP | 2025-12-17 | Sell | 2,147 | $28.84 | $61,919 | 33,831 |
| RAPP | 2025-12-17 | Sell | 600 | $31.04 | $18,624 | 567,913 |
| RAPP | 2025-12-17 | Sell | 2,441 | $28.84 | $70,398 | 571,305 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.
